News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hasara Garrison J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/28/2020 |
4
| Hasara Garrison J. (CFO and Treasurer) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 125,000 options
@ $0.031, valued at
$3.9k
|
|
| 09/21/2020 |
4
| Hasara Garrison J. (CFO and Treasurer) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Granted 100,000 options
@ $0.054, valued at
$5.4k
|
|
| 12/02/2019 |
4
| Hasara Garrison J. (CFO and Treasurer) has filed a Form 4 on Inhibitor Therapeutics, Inc.|
Txns:
| Bought 13,500 shares
@ $0.07, valued at
$945 |
|
| 08/31/2018 |
4
| Hasara Garrison J. (CFO and Treasurer) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Sold 100,000 shares
@ $0.27, valued at
$27k
|
|
| 03/15/2018 |
4
| Hasara Garrison J. (CFO and Treasurer) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.|
Txns:
| Granted 260,000 options
@ $0.2722, valued at
$70.8k
|
|
| 03/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/14/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2012 |
4
| Hasara Garrison J. (Acting CFO) has filed a Form 4 on ACCENTIA BIOPHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $0 |
|
|
|